Latest News & Features
Generics
The US District Court for the District of Delaware has ruled that one of Endo International’s pharma units cannot stop a generic of its blood pressure drug Vasostrict from being made. 2 September 2021
Americas
A US District Court for the District of Delaware jury found that German genetics company Qiagen willfully infringed two patents owned by ArcherDX and Massachusetts General Hospital. 31 August 2021
Americas
Mylan Pharmaceutical and Edwards Lifesciences have joined a petition urging the US Supreme Court to order the US Court of Appeals for the Federal Circuit to reconsider inter partes review petitions that have been denied due to the NHK-Fintiv rule. 31 August 2021
Big Pharma
South Korean officials have urged the US government to help Korean companies gain access to IP related to producing COVID-19 jabs. 31 August 2021
Americas
Kite Pharma has successfully persuaded the US Court of Appeals for the Federal Circuit to reverse a $1.2 billion win for the Bristol-Meyers Squibb owned Juno Therapeutics over a cancer treatment patent. 26 August 2021
Generics
The US Court of Appeals for the Second Circuit has denied an appeal from Takeda Pharmaceuticals to shut down two antitrust suits related to its diabetes drug Actos. 26 August 2021
Biotechnology
The US District Court for the Northern District of Illinois has refused to dismiss a lawsuit from AbbVie which alleges Icelandic pharmaceutical company Alvotech infringed patents related to its arthritis drug Humira. 26 August 2021
article
In the aftermath of the Idenix v Gilead case in 2019 Dmitry Karshtedt and his co-authors published an article in the Harvard Journal of Law & Technology titled “The Death of the Genus Claim” in which they state that “in the past 30 years, there are virtually no significant examples of genus claims in the life science fields upheld on appeal as compliant with §112(a) outside the unique context of ‘interference’ proceedings”. 26 August 2021
Medtech
The US Court of Appeals for the Federal Circuit has invalidated more claims of a Johnson & Johnson subsidiary’s surgical robot patent following a cross-appeal of a Patent Trial and Appeal Board decision. 24 August 2021
Big Pharma
Regeneron wants a Manhattan district court to toss a lawsuit that claims it infringed on patents in the development and testing of COVID-19 treatments. 24 August 2021